Niagen Bioscience (NAGE)

The company’s core asset is Niagen, a branded form of nicotinamide riboside, which is used as an NAD+ precursor. Niagen is positioned as an ingredient that supports increases in NAD+ levels, and it powers a suite of products marketed under the Niagen brand. The company emphasizes clinical research, quality control and intellectual property as important elements of its approach, differentiating itself from many general supplement businesses in a category where scientific substantiation is an important competitive factor.

Niagen Bioscience operates at the intersection of biotechnology, nutrition and consumer wellness. Its products are aimed at people seeking to support healthy aging, cellular energy and long-term healthspan rather than treating a specific disease. That gives the business exposure to the expanding market for longevity and wellness supplements, while also requiring careful communication around scientific claims and regulatory standards.

What distinguishes Niagen Bioscience is its narrow focus on NAD+ science and the commercialization of a branded ingredient platform. Instead of relying on a broad portfolio of unrelated supplements, the company builds its identity around one major biological pathway and related research. Its prospects are tied to consumer adoption, clinical evidence, brand trust and continued interest in healthy-aging solutions.